FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1845521331> ?p ?o ?g. }

• W1845521331 endingPage "116" @default.
• W1845521331 startingPage "109" @default.
• W1845521331 abstract "To evaluate the efficacy, safety and pharmacokinetics of pregabalin in treating neuropathic pain associated with diabetic peripheral neuropathy in Japanese patients.A randomized, double-blind, placebo-controlled, multicentre 14 week clinical trial was conducted. Japanese patients with diabetic peripheral neuropathy (n = 317) were randomized to receive placebo or pregabalin at 300 or 600 mg/day. The primary efficacy measure was a change of mean pain score from baseline to end-point from patients' daily pain diaries.Significant reductions in pain were observed in patients treated with pregabalin at 300 and 600 mg/day vs. placebo (P < 0.05). Improvements in weekly pain scores were observed as early as week 1 and were sustained throughout the study period (300 and 600 mg/day difference from placebo at study end-point, -0.63 and -0.74, respectively). Pregabalin produced significant improvements in weekly sleep interference scores, the short-form McGill Pain Questionnaire, the Medical Outcomes Study-Sleep Scale, the 36-item Short-Form Health Survey scale, and the Patient and Clinical Global Impression of Change. Patient impressions of numbness, pain and paraesthesia were also significantly improved. Regarding treatment responders, 29.1 and 35.6% of patients treated with 300 and 600 mg/day, respectively, reported ≥ 50% improvement in mean pain scores (vs. 21.5% for placebo). Pregabalin was well tolerated; somnolence (26%), dizziness (24%), peripheral oedema (13%) and weight gain (11%) were the most common adverse events and generally were reported as mild to moderate.Pregabalin was effective in reducing pain and improving sleep disturbances due to pain, and was well tolerated in Japanese patients with painful DPN." @default.
• W1845521331 created "2016-06-24" @default.
• W1845521331 creator A5010018060 @default.
• W1845521331 creator A5041031153 @default.
• W1845521331 creator A5046049619 @default.
• W1845521331 creator A5047045330 @default.
• W1845521331 creator A5066429469 @default.
• W1845521331 creator A5067371349 @default.
• W1845521331 creator A5081577782 @default.
• W1845521331 date "2010-12-19" @default.
• W1845521331 modified "2023-10-17" @default.
• W1845521331 title "Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial" @default.
• W1845521331 cites W1533376794 @default.
• W1845521331 cites W1550111394 @default.
• W1845521331 cites W1970747203 @default.
• W1845521331 cites W1972387365 @default.
• W1845521331 cites W1976501333 @default.
• W1845521331 cites W2020267609 @default.
• W1845521331 cites W2020407769 @default.
• W1845521331 cites W2021198854 @default.
• W1845521331 cites W2025827745 @default.
• W1845521331 cites W2032494861 @default.
• W1845521331 cites W2050755481 @default.
• W1845521331 cites W2054260401 @default.
• W1845521331 cites W2068602147 @default.
• W1845521331 cites W2076716839 @default.
• W1845521331 cites W2076964900 @default.
• W1845521331 cites W2103203602 @default.
• W1845521331 cites W2115764075 @default.
• W1845521331 cites W2120306614 @default.
• W1845521331 cites W2153789216 @default.
• W1845521331 cites W2154536095 @default.
• W1845521331 cites W2154893083 @default.
• W1845521331 cites W2158523533 @default.
• W1845521331 cites W2159977024 @default.
• W1845521331 cites W2161059404 @default.
• W1845521331 cites W2161344815 @default.
• W1845521331 cites W2626017884 @default.
• W1845521331 doi "https://doi.org/10.1111/j.1464-5491.2010.03152.x" @default.
• W1845521331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21166852" @default.
• W1845521331 hasPublicationYear "2010" @default.
• W1845521331 type Work @default.
• W1845521331 sameAs 1845521331 @default.
• W1845521331 citedByCount "124" @default.
• W1845521331 countsByYear W18455213312012 @default.
• W1845521331 countsByYear W18455213312013 @default.
• W1845521331 countsByYear W18455213312014 @default.
• W1845521331 countsByYear W18455213312015 @default.
• W1845521331 countsByYear W18455213312016 @default.
• W1845521331 countsByYear W18455213312017 @default.
• W1845521331 countsByYear W18455213312018 @default.
• W1845521331 countsByYear W18455213312019 @default.
• W1845521331 countsByYear W18455213312020 @default.
• W1845521331 countsByYear W18455213312021 @default.
• W1845521331 countsByYear W18455213312022 @default.
• W1845521331 countsByYear W18455213312023 @default.
• W1845521331 crossrefType "journal-article" @default.
• W1845521331 hasAuthorship W1845521331A5010018060 @default.
• W1845521331 hasAuthorship W1845521331A5041031153 @default.
• W1845521331 hasAuthorship W1845521331A5046049619 @default.
• W1845521331 hasAuthorship W1845521331A5047045330 @default.
• W1845521331 hasAuthorship W1845521331A5066429469 @default.
• W1845521331 hasAuthorship W1845521331A5067371349 @default.
• W1845521331 hasAuthorship W1845521331A5081577782 @default.
• W1845521331 hasConcept C118552586 @default.
• W1845521331 hasConcept C126322002 @default.
• W1845521331 hasConcept C134018914 @default.
• W1845521331 hasConcept C14184104 @default.
• W1845521331 hasConcept C142724271 @default.
• W1845521331 hasConcept C1513209611 @default.
• W1845521331 hasConcept C168563851 @default.
• W1845521331 hasConcept C1862650 @default.
• W1845521331 hasConcept C197934379 @default.
• W1845521331 hasConcept C204787440 @default.
• W1845521331 hasConcept C27081682 @default.
• W1845521331 hasConcept C2776432500 @default.
• W1845521331 hasConcept C2776468701 @default.
• W1845521331 hasConcept C2777107010 @default.
• W1845521331 hasConcept C2779034229 @default.
• W1845521331 hasConcept C2779901536 @default.
• W1845521331 hasConcept C2780052408 @default.
• W1845521331 hasConcept C2781118164 @default.
• W1845521331 hasConcept C2781210498 @default.
• W1845521331 hasConcept C42219234 @default.
• W1845521331 hasConcept C555293320 @default.
• W1845521331 hasConcept C71924100 @default.
• W1845521331 hasConceptScore W1845521331C118552586 @default.
• W1845521331 hasConceptScore W1845521331C126322002 @default.
• W1845521331 hasConceptScore W1845521331C134018914 @default.
• W1845521331 hasConceptScore W1845521331C14184104 @default.
• W1845521331 hasConceptScore W1845521331C142724271 @default.
• W1845521331 hasConceptScore W1845521331C1513209611 @default.
• W1845521331 hasConceptScore W1845521331C168563851 @default.
• W1845521331 hasConceptScore W1845521331C1862650 @default.
• W1845521331 hasConceptScore W1845521331C197934379 @default.
• W1845521331 hasConceptScore W1845521331C204787440 @default.
• W1845521331 hasConceptScore W1845521331C27081682 @default.
• W1845521331 hasConceptScore W1845521331C2776432500 @default.

• next